This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chu Nantes, Ecole Nationale Veterinaire, National Institute of Health and Medical Research. Active years: 2020.
Company Filing History:
1 out of 18 
1 out of 1 
1 out of 1,853 
Years Active: 2020
Title: David Riochet: Innovator in Diabetes Treatment
Introduction
David Riochet is a notable inventor based in Nantes, France. He has made significant contributions to the field of diabetes treatment through his innovative research and patents. His work focuses on developing methods to improve the lives of individuals suffering from type 1 diabetes.
Latest Patents
David Riochet holds a patent for "Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes." This invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) for treating type 1 diabetes. The patent also includes methods and kits designed to restore and maintain euglycemia in type 1 diabetic patients and those who are prediabetic.
Career Highlights
Throughout his career, David has worked with esteemed institutions such as Ecole Nationale Veterinaire and Chu Nantes. His experience in these organizations has allowed him to develop and refine his innovative ideas in diabetes treatment.
Collaborations
David has collaborated with notable colleagues, including Jean-Marie Bach and Mathilde Mosser. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
David Riochet is a pioneering inventor whose work in diabetes treatment has the potential to significantly impact the lives of many individuals. His innovative approach to encapsulating insulin-producing cells showcases the importance of research and collaboration in the field of medical science.